GE Aerospace reports news on its aircraft engine, services, and systems business, including commercial engine orders, long-term service support, maintenance, repair and overhaul investments, and digital tools used in production, supply chain, and military aircraft readiness. Coverage includes customer selections for GEnx and other GE Aerospace or CFM-powered fleets, dividend declarations, workforce-training initiatives, and governance matters involving defense-related products.
GE announced the brand names for its future companies following its planned separation into three entities: GE HealthCare for healthcare, GE Vernova for energy, and GE Aerospace for aviation. Each company will leverage GE's $20 billion global brand value. GE HealthCare will be listed on Nasdaq under the symbol GEHC, focusing on innovation in healthcare. GE Vernova will be tasked with sustainable energy solutions and is set for spin-off in early 2024. GE Aerospace will support the aviation sector, maintaining a strong presence with over 39,000 aircraft engines worldwide.
GE announced significant leadership changes at GE Aviation, effective immediately. H. Lawrence Culp, Jr. becomes CEO of GE Aviation while maintaining his role as Chairman and CEO of GE. John Slattery transitions to Executive VP and Chief Commercial Officer. Russell Stokes is promoted to President and CEO of Commercial Engines and Services, while Rahul Ghai joins as CFO. This restructuring follows GE's plan to split into three independent companies focusing on Aviation, Healthcare, and Energy, addressing unprecedented demand and preparing for GE Aviation's transition to a standalone public entity.
IonQ (NYSE: IONQ) and GE have reported early results from their collaboration, demonstrating the application of quantum computing in risk management. They have effectively used quantum models to analyze multi-variable distributions, outperforming classical approaches in some instances. This research holds potential benefits for various sectors including finance and supply chain management. Advances in quantum methodologies may improve decision-making and risk assessment amid volatile market conditions.
GE Healthcare unveiled Portrait Mobile, a wireless patient monitoring system that allows continuous monitoring during hospital stays. This technology aims to detect patient deterioration earlier than traditional methods, potentially reducing ICU admissions and length of stay. The system captures vital signs wirelessly, enabling better patient mobility and early intervention for complications. Developed at GE's center in Helsinki, Portrait Mobile ensures reliable monitoring, leveraging existing hospital networks and improving overall patient outcomes.
The Board of Directors of GE (NYSE: GE) has declared a $0.08 per share dividend on the company's outstanding common stock. This dividend is scheduled for payment on July 25, 2022 to shareholders of record as of the close of business on June 28, 2022. The ex-dividend date is set for June 27, 2022. GE continues to focus on delivering reliable and efficient solutions while maintaining strong engagement with stakeholders.
At the SNMMI 2022 Annual Meeting, GE Healthcare unveiled advanced molecular imaging solutions for prostate cancer, including a new Solid Target Platform for increased Gallium-68 production. This marks the 500th installation of their cyclotron, enhancing access to critical radioisotopes used in PET imaging. The company emphasizes the role of theranostics in personalized cancer care, especially after FDA approvals for relevant therapies like Lutetium-177 PSMA-617. GE Healthcare aims to improve patient outcomes and facilitate dedicated theranostics centers globally.
GE Digital has achieved AWS Energy Competency status, demonstrating its expertise in leveraging AWS technology for the energy sector. This recognition highlights GE Digital’s Asset Performance Management (APM) software, designed to enhance the performance, reliability, and cost-efficiency of energy production. The APM solutions are critical as energy industries transition towards more renewable sources. The AWS partnership enables GE Digital to further support clients in achieving their energy transition goals.
Summary not available.
GE Healthcare is enhancing cancer care through strategic collaborations, aiming to improve patient outcomes and clinical efficiency. The company has partnered with various organizations, including RaySearch and Elekta, to integrate imaging and radiation solutions. These efforts focus on precision medicine, utilizing AI and data analytics to streamline oncology treatments. Highlights include advancements in radiation therapy planning and the introduction of innovative diagnostic tools. GE Healthcare operates in a $17.7 billion market, emphasizing its commitment to multidisciplinary cancer care.
GE Healthcare and Medtronic announced the FDA 510(k) clearance and CE Mark approval for integrating their advanced Microstream™ capnography and INVOS™ regional oximetry technologies into the CARESCAPE precision monitoring platform. This collaboration aims to enhance patient outcomes by providing real-time, continuous monitoring, which helps in predicting and preventing perioperative complications. The integration supports improved clinical efficiency, safety, and quality of care, ultimately aiding clinicians in delivering personalized patient care.